AOA Dx Presents New Data at AACR 2026 Advancing a Multi-Omic Blood Test for Early Ovarian Cancer Detection
Denver, CO | April 20, 2026 — AOA Dx today announced the presentation of two new studies at the American Association for Cancer Research (AACR) Annual Meeting 2026, demonstrating significant advancement toward a non-invasive, blood-based test for the early detection of ovarian cancer in women experiencing signs and symptoms. The company is actively preparing for […]